Development of a dissolution medium for nimodipine tablets based on bioavailability evaluation

European Journal of Pharmaceutical Sciences

Volumn 21, Issue 4, 2004, Pages 487-491

  He, Zhonggui ^a   Zhong, Dafang ^a   Chen, Xiaoyan ^a   Liu, Xiaohong ^a   Tang, Xing ^a   Zhao, Limei ^b  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Bioavailability; Dissolution; Nimodipine

Indexed keywords

ACETIC ACID; BUFFER; DODECYL SULFATE SODIUM; NIMODIPINE; SONGSHU;

ADULT; AREA UNDER THE CURVE; ARTICLE; COMMERCIAL PHENOMENA; CONTROLLED STUDY; DISSOLUTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG SOLUBILITY; EVALUATION; HEALTH STATUS; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; PH; PRIORITY JOURNAL; RANDOMIZATION; SINGLE DRUG DOSE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TABLET; TANDEM MASS SPECTROMETRY; VOLUNTEER;

ADULT; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; DRUG EVALUATION, PRECLINICAL; HUMANS; MALE; NIMODIPINE; SOLUBILITY; TABLETS;

EID: 1442333455     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2003.11.009     Document Type: Article

References (10)

1. Babu G.V.M.M., Prasad C.D.S., Murthy K.V.R. Evaluation of modified gum karaya as carrier for the dissolution enhancement of poorly water-soluble drug nimodipine. Int. J. Pharm. 234:2002;1-17.
2. British Pharmacopoeia 2000. The stationary office. London, pp. 2125-2126.
3. Grunenberg A., Keil B., Henck J.O. Polymorphism in binary mixture, as exemplified by nimodipine. Int. J. Pharm. 118:1995;11-21.
4. Löbenberg R., Krämer J., Shah M.P., Amidon G.L., Dressman J.B. Dissolution testing as a prognostic tool for oral drug absorption: dissolution behavior of glibenclamide. Pharm. Res. 17:2000;439-444.
5. Manhold R. Nimodipine. Drugs Today. 21:1985;533-536.
6. Nicklasson M., Brodin A. The relationship between dissolution rates and solubilities in the water-ethanol binary solvent system. Int. J. Pharm. 18:1984;149-156.
7. Qureshi S.A., McGilveray I.J. Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product. Eur. J. Pharm. Sci. 7:1999;249-258.
8. Shah V.P., Konecny J.J., Everett R.L., McCullough B., Noorizadeh A.C., Skelly J.P. In vitro dissolution profile of water-insoluble drug dosage forms in the presence of solubilizers. Pharm. Res. 6:1989;612-618.
9. Shi X.J., Wang H.T., Wei Y., Zhang J.H., Zhang L.L., Zhong M.K. Comparison of bioavailability between nimotop and nimodipine tablet. Yao Xue Xue Bao. 32:1997;708-710.
10. Swanepoel E., Liebenberg W., Devarakonda B., Villiers M.M. Developing a discriminating dissolution test for three mebendazole poly-morphs based on solubility differences. Pharmazie. 58:2003;117-121.